Dogwood Therapeutics
DWTX | NASDAQ
$1.06
-$0.05 (-4.50%)
At close: Nov 16, 2026, 4:00 PM ET
$1.11
+$0.05 (+4.72%)
After-hours:
Nov 16, 2026, 7:36 PM ET
-4.50%
(1D)No price chart data available for 1D timeframe.
Rating
40.5
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #516/1021 (Top 51%)
Key Statistics
Market Data
Market Cap $40.52M
1D Range
1.00 1.16
52W Range
1.00 6.82
Valuation (TTM)
PE -1.19
PB 0.00
EV/EBITDA -2.04
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $12.00
Cash Flow
FCF Yield -40.6%
SBC Adj. FCF Yield -44.9%
SBC Impact -10.4%
Margins
Gross Margin -4.8%
Operating Margin -18672.6%
FCF Margin -16471.8%
Growth (CAGR)
Revenue 3Y | 5Y 150.0% |
100.0%
Dil EPS 3Y | 5Y 25.6% |
41.3%
FCF 3Y | 5Y -47.8% |
-14.5%
Returns
ROA -33.3%
ROE -35.0%
ROIC -23.1%
Financial Health
Net Cash
$4.95T
Current Ratio 2.78
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions ...
Sector Healthcare
Industry Biotechnology
Employees 8
IPO Date Dec 17, 2020
Website www.dwtx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 5, 2026
EPS
-$0.14
Beat +9.68%
YoY:
+98.29% REV
$100K
Beat 0.00%
Next Earnings
Mar 17, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$12.00
Upside
+1032.08%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove DWTX